Cargando…
Multiple myeloma cancer stem cells
Multiple myeloma (MM) remains incurable despite much progress that has been made in the treatment of the disease. MM cancer stem cell (MMSC), a rare subpopulation of MM cells with the capacity for self-renewal and drug resistance, is considered to lead to disease relapse. Several markers such as sid...
Autores principales: | Gao, Minjie, Kong, Yuanyuan, Yang, Guang, Gao, Lu, Shi, Jumei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5085244/ https://www.ncbi.nlm.nih.gov/pubmed/27007154 http://dx.doi.org/10.18632/oncotarget.8154 |
Ejemplares similares
-
Smoldering Multiple Myeloma
por: Gao, Minjie, et al.
Publicado: (2015) -
Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2
por: Gao, Lu, et al.
Publicado: (2015) -
Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I
por: Yang, Guang, et al.
Publicado: (2015) -
Early versus Deferred Treatment for Smoldering Multiple Myeloma: A Meta-Analysis of Randomized, Controlled Trials
por: Gao, Minjie, et al.
Publicado: (2014) -
TRIP13 impairs mitotic checkpoint surveillance and is associated with poor prognosis in multiple myeloma
por: Tao, Yi, et al.
Publicado: (2017)